Cheiron Pharma has repeatedly attended the CPhI in Istanbul (March 7th – 9th, 2017) in order to strengthen the relations with its customers in that important market. This was the last time in Istanbul as he fair will move to Abu Dhabi (September 2018) due to the shifted focus on the MENA region.
(Business review 2016)
In 2016, the services of Cheiron Pharma have reached a record high with more than 100 customers in more than 20 countries with about 200 different products.
Only 4 months after receipt of the NARCOTIC LICENCE, Cheiron Pharma has started successfully the business in that product range with active pharmaceutical ingredients (like Codeine Phosphate, Fentanyl Citrate, Remifentanyl HCL, and others).
Carsten Loebel and Stefan Thomsen will attend the CPhI in Barcelona (Oct. 4th-6th, 2016). We are looking forward to meeting you there for fruitful business discussions.
Cheiron Pharma has received the Narcotic License as per § 3 BtMG (as per Narcotic Drug Law) and is including controlled substances in its product portfolio.